Steven Dupont

Steven N. Dupont

Senior Counsel

Steven N. Dupont focuses on the corporate, licensing, and transactional needs of established and emerging life science, medical device, biotechnology, biopharmaceutical, technology, and natural products companies. He has extensive experience in representing public and private companies in complex intellectual property licensing and strategic corporate alliances.

Steven served as Executive Vice President of Corporate Development and General Counsel at Pharmion Corp. In that role, he was responsible for all of the company's legal and business development functions, and led the company through its $2.9 billion acquisition by Celgene. Before entering law school, Steven was a process control engineer who designed real-time, computer-based process control systems for a variety of applications.


Representative Matters

  • Represented specialty pharmaceutical companies in asset in-licensing and acquisitions
  • Represented biotechnology companies in the structuring and negotiation of major drug discovery and development collaboration alliances
  • Represented biotechnology and medical device companies in companion diagnostics development alliances

Professional Highlights

Professional Activities

Colorado Bar Association

Colorado BioScience Association

Colorado Cleantech Industries Association

Board Memberships & Community Service

Boulder Philharmonic Orchestra, 2002-2004

Advisory Board, A Precious Child, 2012-2016



Chicago-Kent College of Law, Illinois Institute of Technology (J.D. 1993, with high honors)
Order of the Coif
Executive Articles Editor, Chicago-Kent Law Review

Worcester Polytechnic Institute (B.S.M.E. 1981, with honors)
Member, Pi Tau Sigma and Tau Beta Pi engineering honor societies



U.S. Patent and Trademark Office